StockDuty ← Dashboard Aug 14, 2026 04:00 AM ET
SignalCorporate

HEALTH IN TECH REAFFIRMS $45M-$50M 2026 REVENUE GUIDANCE WHILE PREPARING HITRIX LAUNCH IN THE SECOND HALF - SEEKINGALPHA

Reaffirmed $45M-$50M 2026 guidance plus H2 Hitrix launch catalyst.

What changed
Reaffirmed $45M-$50M 2026 guidance plus H2 Hitrix launch catalyst.
Why it matters
Reaffirmed $45M-$50M 2026 guidance plus H2 Hitrix launch catalyst. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →